The Effect of Percussion Massage Therapy on the Recovery of DOMS in Physically Active Young Men Delayed Onset Muscle Soreness = DOMS (Required)

September 21, 2024 updated by: Haiwei Li, Shanxi Normal University

The Effect of Percussion Massage Therapy on the Recovery of Delayed Onset Muscle Soreness in Physically Active Young Men

The goal of this clinical trial is to learn the effect of percussion massage therapy (PMT) on the recovery of delayed onset muscle soreness (DOMS) in physically active young men.

The main question it aims to answer is:

Compared with static stretching, Do 25 minutes and 40 minutes of PMT can decrease pain and increase the rang of motion of knee of low limb DOMS in physically active young men? Compared with static stretching, Do 25 minutes and 40 minutes of PMT sessions can increase power and improve the neuromuscular electrophysiology of low limb DOMS in physically active young men?

Researchers will compare 25 minutes and 40 minutes of PMT to a static stretching to see if different times of PMT are better to treat DOMS.

Participants will: Undergo squats to induce low limb DOMS. Receive static stretching, 25 minutes and 40 minutes of PMT, respectively for three times.

Visit the lab for four times in one week for tests.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Taiyuan, Shanxi, China, 030031
        • Shanxi Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Regularly participate in physical activity, have no contraindications to exercise, and volunteered to participate in this study

Exclusion Criteria:

Participants consumed alcohol and exercised vigorously throughout the formal experiment or they underwent interventions other than those planned for the experiment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Static Stretching group
The static stretching protocol comprised eight exercises, performed for 30 seconds per bilateral muscle group (with the exception of the sitting toe touch and butterfly stretch), and included the hip, knee, and ankle. Each subject completed each stretch before progressing to the subsequent one. The stretches were maintained until the subject experienced mild discomfort, but not pain.
The static stretching protocol comprised eight exercises, performed for 30 seconds per bilateral muscle group (with the exception of the sitting toe touch and butterfly stretch), and included the hip, knee, and ankle. The subjects were instructed to perform the following sequence of stretches: forward lunge, supine knee flexion, lateral quadriceps stretch, sitting toe touch, semi-straddle, straddle, butterfly stretch, and a straight knee ankle extensor wall stretch. Each subject completed each stretch before progressing to the subsequent one. The stretches were maintained until the subject experienced mild discomfort, but not pain.
Experimental: short-time PMT group
The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. In the S-PMT group, the treatment was applied for 25minutes.
The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head and the vibration frequency was 53 Hz. The targeted muscles included the quadriceps, adductors, hamstrings, iliotibial band, and gluteal muscles for both sides. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. The short time PMT was applied for 2.5 minutes per muscle site for a total of 25 minutes.
Experimental: long-time PMT group
The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. In the L-PMT group, the treatment was applied for 40 minutes.
The PMT was performed by the two physiotherapists using an OUTSO 06® Fascia Gun equipped with a 5 cm diameter soft attachment head and the vibration frequency was 53 Hz. The targeted muscles included the quadriceps, adductors, hamstrings, iliotibial band, and gluteal muscles for both sides. Throughout the PMT, the physiotherapists carefully maintained a consistent level of moderate pressure on the skin, and followed the direction of the muscle fibers. The long time PMT was applied for 4 minutes per muscle site for a total of 40 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle pain
Time Frame: From enrollment to the end of treatment for 3 days
The intensity of muscle pain was quantified using the visual analogue scale (VAS), which comprises a 10-cm straight line with one end labelled (score of 0) and the other end labelled intolerable pain (score of 10). Subjects were required to provide a rating of their perceived lower-limb muscle soreness for each leg on a scale of one (no soreness) to ten (maximal soreness). Two measurements were recorded on the VAS scale, and the average was calculated.
From enrollment to the end of treatment for 3 days
Knee joint ROM
Time Frame: From enrollment to the end of treatment for 3 days
A modified kneeling lunge was employed to assess knee joint ROM. The procedure was as follows: the subjects left leg was bent at the knee, the thigh was parallel to the ground, and the left lower leg was perpendicular to the ground; the right leg was bent at the knee, and the upper body was maintained in an upright position. The subject was required to adjust the position in order to stretch the right hip to the point of discomfort. The angle to which the right hip was stretched was measured and used as a criterion for subsequent measurement of the ROM. The investigator then bent the subjects right knee until the level of discomfort was reached. At this point, the angle between the thigh and calf was recorded using a goniometer, with the following landmarks: the lateral malleolus, the lateral epicondyle, and the center of the vastus lateralis. A larger angle indicated a smaller ROM of the knee joint.
From enrollment to the end of treatment for 3 days
CMJ
Time Frame: From enrollment to the end of treatment for 3 days
The CMJ was performed in accordance with the established methodology described in the existing literature, and the variables with the CMJ were evaluated using a BTS P-6000 three-dimensional force platform (BTS Bioengineering, Milan, Italy), with a sampling frequency of 1000 Hz. Three trials were conducted for each subject, and the highest vertical jump height was selected for analysis. The variables obtained included the jump height, the peak ground reaction force during the propulsion phase, and the propulsion impulse. The jump height was calculated from the time spent in the air. The peak ground reaction force was obtained from the force-time curve, and the calculation of the propulsion impulse was based on the previous literature.
From enrollment to the end of treatment for 3 days
Surface EMG
Time Frame: From enrollment to the end of treatment for 3 days
In this study, wireless sEMG (Noraxon USA Inc., Scottsdale, AZ, USA) was employed to collect the integrated EMG (iEMG) from the vastus medialis, rectus femoris, and vastus lateralis during the completion of the CMJ on the dominant leg, with a sampling frequency of 1000 Hz. The skin surface was prepared by abrasion and alcohol swabs. Disposable Ag-AgCl circular surface electrodes (4 mm diameter) were filled with electrode jelly and attached 2.5 cm apart to each muscle. Once the EMG test was complete, the raw data were processed using Noraxon TeleMyo (Noraxon USA Inc., Scottsdale,AZ, USA) software for rectification, smoothing, and filtering. In order to eliminate the effect of time phase, the signal was partitioned in 10-ms windows to find for each muscle and each subject its maximal activation over CMJ (iEMGmax). iEMGmax was considered to be 100%. Then, the iEMG of CMJ duration was divided by the time (iEMG/T) and expressed in percentage iEMGmax.
From enrollment to the end of treatment for 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

July 15, 2024

Study Completion (Actual)

July 21, 2024

Study Registration Dates

First Submitted

September 21, 2024

First Submitted That Met QC Criteria

September 21, 2024

First Posted (Actual)

September 25, 2024

Study Record Updates

Last Update Posted (Actual)

September 25, 2024

Last Update Submitted That Met QC Criteria

September 21, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delayed Onset Muscle Soreness (DOMS)

Clinical Trials on Static stretching

Subscribe